from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2974c/-

LFCtreatmentdescriptionclass of inhibitor

-0.001

Amikacinug/mL Amikacintranslation

-0.355

Cap5-10ug/mL Capreomycintranslation

-0.254

Rox10-50 ug/mL Roxithromycintranslation

-0.020

SM2-5 ug/mL Streptomycintranslation

0.654

Tet5-10 ug/mL Tetracyclinetranslation

0.783

Rif0.2-5ug/mL Rifampicintranscription

-0.627

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.961

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.379

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.432

CPZ10-50 ug/mL Chlorpromazinerespiration

1.656

Clofazimine10-13 ug/mL Clofaziminerespiration

0.461

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.256

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.005

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.693

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.338

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.446

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.192

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.105

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.540

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.101

KCN5-20 ug/mL Potassium cyaniderespiration

-0.013

NaN30.2-2 mM Sodium aziderespiration

-0.453

Nigericin50 uM Nigericinrespiration

0.334

TRC10-150 ug/mL Triclosanrespiration

0.428

TRZ10-25 ug/mL Thioridazinerespiration

1.129

Valinomycin0.5-10 uM Valinomycinrespiration

-0.283

ZnSO42 mM ZnSO4respiration

0.757

menadione6-10 ug/mL Menadionerespiration

0.285

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.375

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.064

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.430

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.541

NRP_1Non-replicating persistence stage 1dosRassociated

-0.377

Amp0.2mg/mL AmpicillincellWall

0.259

Cephalexin20-100 ug/mL CephalexincellWall

-0.168

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.021

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.277

EMB10-20 ug/mL EthambutolcellWall

0.199

Eta12-40 ug/mL EthionamidecellWall

0.053

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.118

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.031

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.066

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.046

BZA0.12 mg/mL BenzamidearomaticAmides

-0.272

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.161

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.308

H2O24 mM hydrogen peroxideDNAdamaging

0.069

Levo10 ug/mL LevofloxacinDNAdamaging

-1.148

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.279

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.271

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.325

UVUV-irradiationDNAdamaging

1.712

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.132

Antimycin12.5-50 ug/mL Antimycin A?

0.421

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.074

PA_110-50 ug/mL Antitubercular compound PA-1?

0.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.311

PA8240.2-2 ug/mL PA-824?

1.310

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.163

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.239

Verapamil50 uM Verapamil?

0.335

mercaptoethanol2 mM 2-Mercaptoethanol?

0.253

methoxatin10-20 ug/mL Methoxatin?